Table 2 Patient comorbidity profile
From: Incidence and medical costs of lupus in Spanish hospitals: a retrospective database analysis
Index admission | p-valuea | |
|---|---|---|
Admissions, N | 416 | - |
Mean CCI | 2.75 | < 0.0001 |
Median CCI | 2 | - |
CCI 0, N (%) | 1 (0.30) | < 0.0001 |
CCI 1, N (%) | 29 (8.81) | < 0.0001 |
CCI 2, N (%) | 177 (53.80) | < 0.0001 |
CCI 3, N (%) | 45 (13.68) | < 0.0001 |
CCI 4, N (%) | 36 (10.94) | < 0.0001 |
CCI 5, N (%) | 23 (6.99) | < 0.0001 |
CCI > 5, N (%) | 18 (5.47) | < 0.0001 |
Mean updated CCI | 2.38 | < 0.0001 |
Median updated CCI | 2 | - |
CCI 0, N (%) | 4 (1.22) | < 0.0001 |
CCI 1, N (%) | 68 (20.67) | < 0.0001 |
CCI 2, N (%) | 164 (49.84) | < 0.0001 |
CCI 3, N (%) | 37 (11.25) | < 0.0001 |
CCI 4, N (%) | 29 (8.81) | < 0.0001 |
CCI 5, N (%) | 10 (3.04) | < 0.0001 |
CCI > 5, N (%) | 17 (5.17) | < 0.0001 |
Secondary diagnoses, > 10% | ||
Essential (primary) hypertension, N (%) | 104 (31.61) | < 0.0001 |
Unspecified asthma, without complications, N (%) | 92 (27.96) | < 0.0001 |
Hyperlipidemia, N (%) | 65 (19.76) | < 0.0001 |
Nicotine dependence, cigarettes, without complications, N (%) | 56 (17.02) | < 0.0001 |
Chronic obstructive pulmonary disease, N (%) | 50 (15.20) | < 0.0001 |
Personal history of nicotine dependence, N (%) | 49 (14.89) | < 0.0001 |
Antiphospholipid syndrome, N (%) | 40 (12.16) | < 0.0001 |
Old myocardial infarction, N (%) | 39 (11.85) | < 0.0001 |
Long-term use of aspirin, N (%) | 35 (10.63) | < 0.0001 |
Mortality rate, % | 3.95 | < 0.0001 |